Dudley & Shanley, Inc. Ocular Therapeutix, Inc Transaction History

Dudley & Shanley, Inc.

  • $581 Million
  • Q4 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025
SELL
$9.09 - $13.6 $30,906 - $46,240
-3,400 Reduced 20.73%
13,000 $151,000
Q2 2025

Jul 09, 2025
BUY
$6.02 - $9.46 $1,204 - $1,892
200 Added 1.23%
16,400 $152,000
Q2 2024

Jul 09, 2024
BUY
$4.2 - $8.69 $68,040 - $140,778
16,200 New
16,200 $110,000

Others Institutions Holding OCUL

# of Institutions
239
Shares Held
160M
Call Options Held
1.24M
Put Options Held
423K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $875M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Dudley & Shanley, Inc. Portfolio

Follow Dudley & Shanley, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dudley & Shanley, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dudley & Shanley, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email